Drugs / Moxidex
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00578773 | Nov 2007 → Jan 2009 | otitis media | Alcon Research | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT01071902 | Feb 2010 → Oct 2011 | otitis media | Alcon Research | Terminated | No outcome recorded |
| Phase 3 | NCT00750633 | Jun 2008 → Jan 2009 | acute otitis externa | Alcon Research | Completed | No outcome recorded |
| Phase 3 | NCT00579189 | Jan 2006 → Jan 2009 | otitis media | Alcon Research | Completed | No outcome recorded |
| Phase 3 | NCT00578474 | Dec 2005 → Aug 2008 | otitis media | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moxidex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00578474 ↗ |
| Route | Other | “Moxidex otic solution” NCT00578474 ↗ |